Modalis Therapeutics Corporation

4883.T
Drug Manufacturers - Specialty & Generic
2026/08/10 Updated
Market Cap: $20.1M (¥3.2B)
Stock Price: $0.21 (¥33)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Recognition of Non-Operating Income and Special Profit

Notice regarding recognition of non-operating income and special profit, including foreign exchange effects. The main content explains the recognition status of items arising from foreign exchange gains/losses and other special items, and the outlook for future impact.

Importance:
Page Updated: August 10, 2026
IR Disclosure Date: August 10, 2026

Key Figures

  • Key figure 1: Unknown (specific amounts are not disclosed in the materials)
  • Key figure 2: Unknown (details such as the impact period and recovery amounts are unknown)
  • Key figure 3: Unknown (future outlook figures are unknown)

AI要約

Section Heading

This document is a notice as of August 2026 regarding the recognition of non-operating income and special profit. It explains that, due to fluctuations in foreign exchange rates, the valuation of certain assets and liabilities of our group will generate items recognized as non-operating income and potential occurrences of special profit. It notes that the timing and amounts recorded may vary depending on future exchange rate trends and market conditions.

Section 2 Heading

For future outlook, it describes that exchange rate movements may affect consolidated results to varying degrees and highlights considerations regarding the timing of recognition under accounting standards. Investors are advised to continuously monitor the latest exchange rate trends and disclosure contents.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Modalis, Inc.

Company overview · Stock price · Financial data · All IR

View company page →